Breaking News Instant updates and real-time market news.

GILD

Gilead

$64.70

0.58 (0.90%)

08:18
06/12/17
06/12
08:18
06/12/17
08:18

Gilead submits NDA for Bictegravir, Emtricitabine, Tenofovir Alafenamide regimen

Gilead Sciences announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for an investigational, once-daily single tablet regimen containing bictegravir, a novel investigational integrase strand transfer inhibitor, and emtricitabine/tenofovir alafenamide for the treatment of HIV-1 infection in adults. BIC/FTC/TAF has demonstrated high rates of virologic suppression and no treatment-emergent resistance through 48 weeks in Phase 3 clinical trials among treatment-naive adult patients and among virologically suppressed adult patients who switched regimens. The NDA for BIC/FTC/TAF is supported by data from four Phase 3 studies in which the regimen met its primary objective of non-inferiority. Three of the ongoing studies are designed to explore the efficacy and safety of BIC/FTC/TAF compared to triple-therapy regimens containing dolutegravir among treatment-naive patients and among virologically suppressed patients switching from an existing antiretroviral regimen with dolutegravir. A fourth ongoing study in virologically suppressed patients compares switching to BIC/FTC/TAF versus remaining on a suppressive regimen of two nucleoside/nucleotide reverse transcriptase inhibitors and a boosted protease inhibitor. Gilead plans to submit a marketing authorization application for BIC/FTC/TAF in the European Union in Q3. Bictegravir in combination with FTC/TAF as a single tablet regimen is an investigational treatment that has not been determined to be safe or efficacious and is not approved anywhere globally.

  • 13

    Jun

GILD Gilead
$64.70

0.58 (0.90%)

05/30/17
JPMS
05/30/17
NO CHANGE
JPMS
Overweight
JPMorgan 'generally encouraged' by Gilead bictegravir data
After Gilead (GILD) announced top-line data from four Phase 3 studies of its HIV combo regimen containing bictegravir, JPMorgan analyst Cory Kasimov said he was "generally encouraged by the news, though not entirely surprised" given the previously communicated Phase 2 results. As he has previously noted, Kasimov thinks the launch of the bictegravir combo in 2018 could be key for Gilead to help maintain market share in the face of continued growth of GlaxoSmithKline's (GSK) dolutegravir combo and a wave of patent expirations. The analyst keeps an Overweight rating on Gilead shares.
05/30/17
LEER
05/30/17
NO CHANGE
Target $74
LEER
Market Perform
Gilead HIV combo data should reassure investors, says Leerink
Leerink analyst Geoffrey Porges said Gilead's (GILD) Phase 3 data for its HIV combination treatment featuring bictegravir should "provide significant reassurance for investors" given that the drug is an essential part of the company's HIV strategy and portfolio and was found to be equal to, though not better than, the "gold standard," namely GlaxoSmithKline's (GSK) dolutegravir combo. Porges, who attributes $12-13 per share in value from bictegravir in his current model for Gilead, notes that his peak global forecast of $10.6B for bictegravir containing combination revenue is nearly double the current consensus peak sales estimate of $5.6B. Porges keeps a Market Preform rating and $74 price target on Gilead shares.
04/25/17
JMPS
04/25/17
NO CHANGE
JMPS
Johsnson &Johnson data positive for Achillion, says JMP Securities
JMP Securities analyst Liisa Bayko says that data on a triple combination HCV treatment presented by Johnson & Johnson (JNJ) yesterday is positive for Achillion (ACHN). The analyst noted that the triple combination includes Achillion's odalasvir and that the six week treatment regimen is shorter than the eight weeks required for Gilead's (GILD) Harvoni. The analyst says that Achillion's stock dropped sharply yesterday because there was disappointment over the combination's efficacy in genotype 3 patients. However, she says that such patients only represent 10% of the total, and she says that Achillion can "conservatively" obtain peak royalty revenue of about $100M from its drug. Bayko keeps a $13 price target and an Outperform rating on the shares.
04/25/17
WELS
04/25/17
NO CHANGE
WELS
Gilead Q1 results poised to beat expectations, says Wells Fargo
After analyzing prescription data for January and February, Wells Fargo says that prescriptions of Gilead's HIV and HCV drugs were tracking ahead of expectations. The firm says the company's Q1 results appear on track to beat expectations.

TODAY'S FREE FLY STORIES

TIF

Tiffany

$88.72

0.22 (0.25%)

06:43
08/24/17
08/24
06:43
08/24/17
06:43
Hot Stocks
Tiffany sees FY17 CapEx $250M »

Sees FY17 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

TIF

Tiffany

$88.72

0.22 (0.25%)

06:42
08/24/17
08/24
06:42
08/24/17
06:42
Earnings
Tiffany sees FY17 EPS growth of high single digits, consensus $3.95 »

Sees FY17 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

TIF

Tiffany

$88.72

0.22 (0.25%)

06:40
08/24/17
08/24
06:40
08/24/17
06:40
Earnings
Tiffany reports Q2 adjusted EPS 92c, consensus 86c »

Reports Q2 revenue $960M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 03

    Oct

  • 04

    Oct

HMLP

Hoegh LNG

$18.60

0.25 (1.36%)

06:38
08/24/17
08/24
06:38
08/24/17
06:38
Earnings
Hoegh LNG reports Q2 EPS 28c, consensus 40c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 12

    Sep

WDC

Western Digital

$88.31

1.66 (1.92%)

, TOSYY

Toshiba, also use TOSBF

$17.28

0.49 (2.92%)

06:38
08/24/17
08/24
06:38
08/24/17
06:38
Periodicals
Western Digital consortium to offer $17.4B for Toshiba chip unit, Reuters says »

A consortium that…

WDC

Western Digital

$88.31

1.66 (1.92%)

TOSYY

Toshiba, also use TOSBF

$17.28

0.49 (2.92%)

TOSBF

Toshiba, also use TOSYY

$2.88

0.064 (2.27%)

KKR

KKR

$18.57

-0.07 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXC

Exelon

$38.32

0.09 (0.24%)

06:36
08/24/17
08/24
06:36
08/24/17
06:36
Conference/Events
Exelon management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

06:35
08/24/17
08/24
06:35
08/24/17
06:35
General news
FX Action: USD-JPY has settled in the lower 109.0s »

FX Action: USD-JPY has…

DXLG

Destination XL

06:34
08/24/17
08/24
06:34
08/24/17
06:34
Conference/Events
Destination XL management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 31

    Aug

  • 28

    Sep

BDC

Belden

$73.25

0.08 (0.11%)

06:34
08/24/17
08/24
06:34
08/24/17
06:34
Conference/Events
Belden management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

  • 06

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:33
08/24/17
08/24
06:33
08/24/17
06:33
Hot Stocks
Hormel Foods acquires Ceratti brand for approximately $104M »

Hormel Foods announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:33
08/24/17
08/24
06:33
08/24/17
06:33
Earnings
Hormel cuts FY EPS view to $1.54-$1.58 from low end of $1.65-$1.71 »

Consensus is $1.65.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:32
08/24/17
08/24
06:32
08/24/17
06:32
Hot Stocks
Hormel Foods says faced 'record-high' input costs for two primary raw materials »

"We generated record…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

AVD

American Vanguard

$20.00

0.15 (0.76%)

06:32
08/24/17
08/24
06:32
08/24/17
06:32
Conference/Events
American Vanguard management to meet with Oppenheimer »

Meeting to be held in St.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

HRL

Hormel Foods

$33.92

-0.46 (-1.34%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Earnings
Hormel Foods reports Q3 EPS 34c, consensus 37c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

WBC

Wabco

$138.46

0.22 (0.16%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Hot Stocks
Wabco to acquire Sheppard for $145M »

WABCO announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Sep

AIN

Albany International

$51.10

-0.2 (-0.39%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Conference/Events
Albany International management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

  • 01

    Sep

  • 28

    Sep

EADSY

Airbus

$20.89

-0.015 (-0.07%)

, DLAKY

Lufthansa

$24.60

-0.04 (-0.16%)

06:31
08/24/17
08/24
06:31
08/24/17
06:31
Periodicals
European regulator, Airbus issue software fix for A350, Reuters reports »

The European Aviation…

EADSY

Airbus

$20.89

-0.015 (-0.07%)

DLAKY

Lufthansa

$24.60

-0.04 (-0.16%)

SINGY

Singapore Airlines

CPCAY

Cathay Pacific

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTD

L Brands

06:30
08/24/17
08/24
06:30
08/24/17
06:30
Conference/Events
L Brands to host sales conference call »

Pre-Recorded August sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

06:30
08/24/17
08/24
06:30
08/24/17
06:30
General news
FX Action: USD-JPY has settled in the lower 109.0s »

FX Action: USD-JPY has…

BRCD

Brocade

$12.25

0.06 (0.49%)

, AVGO

Broadcom

$256.92

1.73 (0.68%)

06:22
08/24/17
08/24
06:22
08/24/17
06:22
Hot Stocks
China conditionally approves Broadcom's proposed acquisition of Brocade »

In a regulatory filing,…

BRCD

Brocade

$12.25

0.06 (0.49%)

AVGO

Broadcom

$256.92

1.73 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 24

    Aug

FB

Facebook

$168.71

-0.93 (-0.55%)

06:20
08/24/17
08/24
06:20
08/24/17
06:20
Periodicals
Facebook taps exec Andrew Bosworth to lead hardware efforts, BI reports »

Facebook has selected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 13

    Sep

GOOG

Alphabet

$927.00

2.31 (0.25%)

, GOOGL

Alphabet Class A

$942.58

2.18 (0.23%)

06:20
08/24/17
08/24
06:20
08/24/17
06:20
Periodicals
Google could unveil new Pixel phones on October 5, Engadget reports »

Google (GOOG) could…

GOOG

Alphabet

$927.00

2.31 (0.25%)

GOOGL

Alphabet Class A

$942.58

2.18 (0.23%)

QCOM

Qualcomm

$52.23

-0.12 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

NADL

North Atlantic Drilling

$1.19

0.02 (1.71%)

06:17
08/24/17
08/24
06:17
08/24/17
06:17
Earnings
North Atlantic Drilling reports Q2 EPS ($2.59), consensus ($2.97) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

BIDU

Baidu

$224.99

-1.12 (-0.50%)

06:16
08/24/17
08/24
06:16
08/24/17
06:16
Hot Stocks
Baidu completes sale of food delivery subsidiary »

Baidu's majority…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$8.57

-0.46 (-5.09%)

06:13
08/24/17
08/24
06:13
08/24/17
06:13
Earnings
Sears reports Q2 adjusted EPS ($1.16), consensus ($2.48) 

One analyst estimate.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.